VeriMomSollte ich valproic acid in der Schwangerschaft meiden? | VeriMom
Valproic acid is a well‑documented human teratogen (increased risk of neural tube and other major malformations and adverse neurodevelopmental outcomes) and is reported with H360 (may damage fertility or the unborn child) in ECHA/registration/SDS sources, which per your calibration maps to h=3. Mechanistically VPA is a histone deacetylase (HDAC) inhibitor with well‑characterised effects on gene expression and placental/embryonic development; placental effects and placental transfer have been reported. Topical cosmetic use would likely give low but measurable systemic exposure compared with therapeutic dosing (so e=1 for pregnancy). (Sources: PubMed systematic reviews and clinical teratology literature; ECHA registration/SDS showing H360; mechanistic reviews on HDAC inhibition).
ECHA regulatory hazard statements
- •H360
- •H362
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- Ist valproic acid in der Schwangerschaft sicher?
- Valproic acid is a well‑documented human teratogen (increased risk of neural tube and other major malformations and adverse neurodevelopmental outcomes) and is reported with H360 (may damage fertility or the unborn child) in ECHA/registration/SDS sources, which per your calibration maps to h=3. Mechanistically VPA is a histone deacetylase (HDAC) inhibitor with well‑characterised effects on gene expression and placental/embryonic development; placental effects and placental transfer have been reported. Topical cosmetic use would likely give low but measurable systemic exposure compared with therapeutic dosing (so e=1 for pregnancy). (Sources: PubMed systematic reviews and clinical teratology literature; ECHA registration/SDS showing H360; mechanistic reviews on HDAC inhibition).
- Ist valproic acid während des Stillens sicher?
- Valproic acid is listed with H362 (may cause harm to breast‑fed children) in ECHA/SDS documents and transfers into breast milk in clinical/toxicology literature; the mechanistic actions that produce developmental neurotoxicity are the same basis for concern. For a cosmetic topical route maternal systemic levels would usually be low, so exposure via breastmilk from cosmetic use is expected to be low but measurable (e=1).
- Ist valproic acid sicher für Babyhaut?
- Hazard remains high because VPA is a confirmed human developmental/teratogenic agent and H360/H362 are reported; mechanism (HDAC inhibition, disruption of developmental signalling) is well characterised. If VPA were present on infant skin (0–3 yrs) dermal absorption is more significant than in adults; per your rules increase exposure by +1 when measurable — cosmetic topical adult e=1 becomes baby e=2. There are no infant‑topical specific safety data showing safe use on baby skin.
- Wie bewertet VeriMom valproic acid?
- VeriMom bewertet valproic acid mit 13/100 (hohes Risiko) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu valproic acid?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu valproic acid basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.